Jaguar Health (JAGX) Change in Cash (2014 - 2026)
Jaguar Health's (JAGX) quarterly Change in Cash came in at $2.2 million in Q1 2026, up 196.54% year-on-year from $752681.4 in Q1 2025, and down 48.15% on a QoQ basis from $4.3 million in Q4 2025.
Jaguar Health (JAGX) Change in Cash (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Change in Cash data on file, last reported at $2.2 million in Q1 2026.
- On a quarterly basis, Change in Cash rose 196.54% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was $4.4 million, a 173.13% increase from a year earlier, with the FY2025 full-year figure at -$170000.0, down 111.09% from the prior year.
- Change in Cash for Q1 2026 stood at $2.2 million, down from $4.3 million in the prior quarter.
- Over the last five years, Change in Cash for JAGX reached as high as $8.9 million in Q1 2023 and fell as low as -$8.4 million in Q2 2022.
- Historically, Change in Cash has averaged -$411000.0 across 5 years, with a median of $405000.0 in 2022.
- Across the five-year window, Change in Cash slumped 2397.63% in 2022 and soared 2097.04% in 2023, its largest moves.
- Year by year, Change in Cash stood at -$5.1 million in 2022, then surged by 163.69% to $3.2 million in 2023, then tumbled by 262.41% to -$5.3 million in 2024, then surged by 181.74% to $4.3 million in 2025, then sank by 48.15% to $2.2 million in 2026.
- Per Business Quant data, the three most recent Change in Cash figures were $2.2 million in Q1 2026, $4.3 million in Q4 2025, and $1.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | -2.44 Mn |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | 243.78 Mn |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn | 417.10 Mn |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn | -153.10 Mn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn | 53.61 Mn |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - | 57.19 Mn |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn | 2.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.23 Mn |
| Dec 31, 2025 | 4.31 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Jun 30, 2025 | -3.48 Mn |
| Mar 31, 2025 | -2.31 Mn |
| Dec 31, 2024 | -5.27 Mn |
| Sep 30, 2024 | -2.78 Mn |
| Jun 30, 2024 | 4.38 Mn |
| Mar 31, 2024 | 5.20 Mn |
| Dec 31, 2023 | 3.24 Mn |
| Sep 30, 2023 | -5.40 Mn |
| Jun 30, 2023 | -5.74 Mn |
| Mar 31, 2023 | 8.90 Mn |
| Dec 31, 2022 | -5.09 Mn |
| Sep 30, 2022 | 1.55 Mn |
| Jun 30, 2022 | -8.44 Mn |
| Mar 31, 2022 | 405,000.00 |
| Dec 31, 2021 | 4.68 Mn |
| Sep 30, 2021 | -19.54 Mn |
| Jun 30, 2021 | -338,000.00 |